Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cellular macromolecules in Cutibacterium acnes refer to the collective set of essential biological polymers, including proteins, nucleic acids, and lipids, that maintain the viability and pathogenicity of this Gram-positive bacterium (Matin T, et al., StatPearls, 2023). Cutibacterium acnes (formerly Propionibacterium acnes) is a commensal of human skin but plays a central role in the pathogenesis of acne vulgaris by colonizing the pilosebaceous unit and inducing inflammatory responses (Dréno B, et al., J Eur Acad Dermatol Venereol, 2018). Therapeutic agents targeting these macromolecules often employ non-specific mechanisms, such as the release of reactive oxygen species by benzoyl peroxide, which oxidizes bacterial proteins and disrupts cellular integrity (Matin T, et al., StatPearls, 2023). Other treatments, like azelaic acid, interfere with bacterial protein synthesis and metabolic processes to exert antimicrobial effects (PubChem, CID 2266). Because this target represents a broad category rather than a single molecular entity, it encompasses various essential pathways required for bacterial growth and survival. Effective targeting of these components reduces bacterial load and suppresses the production of pro-inflammatory mediators, thereby alleviating acne symptoms.
Non-specific oxidation of bacterial proteins and lipids; inhibition of protein synthesis via ribosomal binding; disruption of metabolic pathways and cellular integrity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cellular macromolecules (Cutibacterium acnes).